143 related articles for article (PubMed ID: 27110687)
1. Liver-specific overexpression of LPCAT3 reduces postprandial hyperglycemia and improves lipoprotein metabolic profile in mice.
Cash JG; Hui DY
Nutr Diabetes; 2016 Apr; 6(4):e206. PubMed ID: 27110687
[TBL] [Abstract][Full Text] [Related]
2. Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice.
Li Z; Jiang H; Ding T; Lou C; Bui HH; Kuo MS; Jiang XC
Gastroenterology; 2015 Nov; 149(6):1519-29. PubMed ID: 26226572
[TBL] [Abstract][Full Text] [Related]
3. Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion.
Rong X; Wang B; Dunham MM; Hedde PN; Wong JS; Gratton E; Young SG; Ford DA; Tontonoz P
Elife; 2015 Mar; 4():. PubMed ID: 25806685
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression.
Li Z; Ding T; Pan X; Li Y; Li R; Sanders PE; Kuo MS; Hussain MM; Cao G; Jiang XC
J Biol Chem; 2012 Jun; 287(24):20122-31. PubMed ID: 22511767
[TBL] [Abstract][Full Text] [Related]
5. Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia.
Labonté ED; Kirby RJ; Schildmeyer NM; Cannon AM; Huggins KW; Hui DY
Diabetes; 2006 Apr; 55(4):935-41. PubMed ID: 16567514
[TBL] [Abstract][Full Text] [Related]
6. Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.
Singh AB; Liu J
J Biol Chem; 2017 Jan; 292(3):884-897. PubMed ID: 27913621
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidylcholine Acyltransferase-3 Expression Is Associated with Atherosclerosis Progression.
Tanaka H; Zaima N; Sasaki T; Yamamoto N; Inuzuka K; Yata T; Iwaki T; Umemura K; Sano H; Suzuki Y; Urano T; Setou M; Unno N
J Vasc Res; 2017; 54(4):200-208. PubMed ID: 28683445
[TBL] [Abstract][Full Text] [Related]
8. Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis.
Kakisaka K; Suzuki Y; Fujiwara Y; Suzuki A; Kanazawa J; Takikawa Y
J Gastroenterol Hepatol; 2019 Jul; 34(7):1256-1262. PubMed ID: 30160786
[TBL] [Abstract][Full Text] [Related]
9. Small Intestine but Not Liver Lysophosphatidylcholine Acyltransferase 3 (Lpcat3) Deficiency Has a Dominant Effect on Plasma Lipid Metabolism.
Kabir I; Li Z; Bui HH; Kuo MS; Gao G; Jiang XC
J Biol Chem; 2016 Apr; 291(14):7651-60. PubMed ID: 26828064
[TBL] [Abstract][Full Text] [Related]
10. Liver x receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: a key role for lysophosphatidylcholine acyltransferase 3.
Ishibashi M; Varin A; Filomenko R; Lopez T; Athias A; Gambert P; Blache D; Thomas C; Gautier T; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1171-9. PubMed ID: 23580142
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic reduction of lysophospholipids in the digestive tract recapitulates the metabolic benefits of bariatric surgery and promotes diabetes remission.
Cash JG; Konaniah E; Hegde N; Kuhel DG; Watanabe M; Romick-Rosendale L; Hui DY
Mol Metab; 2018 Oct; 16():55-64. PubMed ID: 30087032
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase.
Zhao Y; Chen YQ; Bonacci TM; Bredt DS; Li S; Bensch WR; Moller DE; Kowala M; Konrad RJ; Cao G
J Biol Chem; 2008 Mar; 283(13):8258-65. PubMed ID: 18195019
[TBL] [Abstract][Full Text] [Related]
13. Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in skeletal muscle.
Ferrara PJ; Rong X; Maschek JA; Verkerke AR; Siripoksup P; Song H; Green TD; Krishnan KC; Johnson JM; Turk J; Houmard JA; Lusis AJ; Drummond MJ; McClung JM; Cox JE; Shaikh SR; Tontonoz P; Holland WL; Funai K
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33591957
[TBL] [Abstract][Full Text] [Related]
14. Targeting phospholipid remodeling pathway improves insulin resistance in diabetic mouse models.
Tian Y; Lu W; Shi R; McGuffee R; Lee R; Ford DA; Wang B
FASEB J; 2023 Nov; 37(11):e23251. PubMed ID: 37823674
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport.
Hashidate-Yoshida T; Harayama T; Hishikawa D; Morimoto R; Hamano F; Tokuoka SM; Eto M; Tamura-Nakano M; Yanobu-Takanashi R; Mukumoto Y; Kiyonari H; Okamura T; Kita Y; Shindou H; Shimizu T
Elife; 2015 Apr; 4():. PubMed ID: 25898003
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of lysophospholipid acyltransferase, LPLAT10/LPCAT4/LPEAT2, in the mouse liver increases glucose-stimulated insulin secretion.
Shimizu K; Ono M; Mikamoto T; Urayama Y; Yoshida S; Hase T; Michinaga S; Nakanishi H; Iwasaki M; Terada T; Sakurai F; Mizuguchi H; Shindou H; Tomita K; Nishinaka T
FASEB J; 2024 Jan; 38(2):e23425. PubMed ID: 38226852
[TBL] [Abstract][Full Text] [Related]
17. Hyperuricemia induces lipid disturbances mediated by LPCAT3 upregulation in the liver.
Liu N; Sun Q; Xu H; Yu X; Chen W; Wei H; Jiang J; Xu Y; Lu W
FASEB J; 2020 Oct; 34(10):13474-13493. PubMed ID: 32780898
[TBL] [Abstract][Full Text] [Related]
18. LPCAT3/LPLAT12 deficiency in the liver ameliorates acetaminophen-induced acute liver injury.
Inagaki NF; Nakanishi H; Ohto T; Shindou H; Shimizu T
FASEB J; 2024 Jan; 38(1):e23328. PubMed ID: 38019192
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Phospholipid Remodeling Modulates Insulin Sensitivity and Systemic Metabolism.
Tian Y; Mehta K; Jellinek MJ; Sun H; Lu W; Shi R; Ingram K; Friedline RH; Kim JK; Kemper JK; Ford DA; Zhang K; Wang B
Adv Sci (Weinh); 2023 Jun; 10(18):e2300416. PubMed ID: 37088778
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity.
He M; Li Z; Tung VSK; Pan M; Han X; Evgrafov O; Jiang XC
Diabetes; 2023 Nov; 72(11):1547-1559. PubMed ID: 37625119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
